Germany
Japan
United Kingdom
China
Rabbit Polyclonal anti-CFTR Antibody
| Applications | ICC/IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human CFTR |
TA890106 is the same product as TA374684.
Endosomal Marker Antibodies
View as table Download
Rabbit Polyclonal antibody to Caveolin 2 (caveolin 2)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human (Predicted: Rat, Dog, Feline, Pig, Rabbit, Sheep, Bovine, Rhesus Monkey, Mouse) |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region within amino acids 1 and 45 of Caveolin 2 |
Rabbit polyclonal ERBB2 Antibody(N-term)
| Applications | FC, IHC, WB |
| Reactivities | Human (Predicted: Mouse, Rat) |
| Conjugation | Unconjugated |
| Immunogen | This ERBB2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 21-52 amino acids from the N-terminal region of human ERBB2. |
Rabbit polyclonal EGFR (Thr693) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human EGFR around the phosphorylation site of threonine 693 (P-L-TP-P-S). |
| Modifications | Phospho-specific |
Rabbit polyclonal HER2 (Tyr1248) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | HER2 (phospho-Tyr1248) antibody detects endogenous levels of HER2 only when phosphorylated at tyrosine 1248. |
| Modifications | Phospho-specific |
Rabbit polyclonal anti-EGFR antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | This whole rabbit serum was prepared by repeated immunizations with a peptide synthesized using conventional technology. The sequence of the epitope maps to a region near the carboxy terminus which is identical in human, mouse and rat EGFR. |
Rabbit polyclonal antibody to CACNA1S (calcium channel, voltage-dependent, L type, alpha 1S subunit)
| Applications | IHC, WB |
| Reactivities | Human (Predicted: Mouse, Feline, Rabbit, Rat) |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 544 and 885 of CACNA1S (Uniprot ID#Q13698) |
Rabbit polyclonal EGFR (Ser1026) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human EGFR around the phosphorylation site of serine 1026 (F-S-SP-P-S). |
| Modifications | Phospho-specific |
Rabbit polyclonal Phospho-ERBB2(Y877) Antibody
| Applications | Dot, WB |
| Reactivities | Human (Predicted: Mouse, Rat) |
| Conjugation | Unconjugated |
| Immunogen | This ERBB2 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding Y877 of human ERBB2. |
| Modifications | Phospho-specific |
Active filters
Reactivities
- Rat
Antibody Hosts
- Rabbit
Isotypes
- IgG
Conjugates
- Unconjugated
Families
- Transmembrane
Filter by
Category
Target Symbol
Clonalities
Modifications
Pathways
- Focal adhesion (46)
- Calcium signaling pathway (45)
- Adherens junction (41)
- Bladder cancer (41)
- Endometrial cancer (41)
- ErbB signaling pathway (41)
- Non-small cell lung cancer (41)
- Pancreatic cancer (41)
- Pathways in cancer (41)
- Prostate cancer (41)
- MAPK signaling pathway (31)
- GnRH signaling pathway (30)
- Endocytosis (29)
- Gap junction (29)
- Colorectal cancer (28)
- Cytokine-cytokine receptor interaction (28)
- Dorso-ventral axis formation (28)
- Epithelial cell signaling in Helicobacter pylori infection (28)
- Glioma (28)
- Melanoma (28)
- Regulation of actin cytoskeleton (28)
- Viral myocarditis (4)
- Dilated cardiomyopathy (3)
- ABC transporters (2)
- Alzheimer's disease (2)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (2)
- Cardiac muscle contraction (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- Type II diabetes mellitus (2)
- Vascular smooth muscle contraction (2)
- Vibrio cholerae infection (2)
- Neuroactive ligand-receptor interaction (1)